YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Efficient Synthesis of 2-Aminoindan and cis-(${\pm}$)-4,4a,5,9b-tetrahydroindeno[1,2-b][1,4]oxazin-3(2H)-one

2-Aminoindan 및 cis- ( ${\pm}$ ) -4,4a,5,9b-tetrahydroindeno[1,2-b][1,4]oxazin-3(2H)-one의 효율적 합성

  • Kim, Min-Woo (College of Pharmacy, Catholic University of Daegu) ;
  • Ma, Eun-Sook (College of Pharmacy, Catholic University of Daegu)
  • 김민우 (대구가톨릭대학교 약학대학) ;
  • 마은숙 (대구가톨릭대학교 약학대학)
  • Published : 2006.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

1-Amino-5,6-dimethoxyindan hydrochloride was synthesized from 3- (3,4-dirnethoxyphenyl)propionic acid by intramolecular Friedel-Crafts acylation, oximation with hydroxylamine, and reduction with an overall yield of 74%. 2-Amino-5,6-dimethoxyindan hydrochloride was synthesized from 3-(3,4-dirnethoxyphenyl)propionic acid by intramolecular Friedel-Crafts acylation, oximation with isoamylnitrite, reduction in NaOH and reaction with HCI to form 5,6-dimethoxy-2-indanone, which was reacted with hydroxylamine and reduced with an overall yield of 42%. 5,6-Dimethoxyindan-1,2-dione-2-oxime, which was catalytically hydrogenated to afford cis-, and trans-1-amino-5,6-dimethoxyindan-1-ol as 3 : 1 ratio. This mixture was treated with Li and reacted with chloroacetyl chloride. Cis isomer was acylated and cyclized to synthesize rir -( ${\pm}$ )-7,8-dimethoxy-4,4a,5,9b-tetrahydroindeno[1,2-b][1,4]oxazin-3(2H)-one, but trans isomer was just acylated to form amide.

Keywords

References

  1. Jackson, D. M. and Westland-Danielsson, A. : Dopamine receptors: Molecular biology, biochemistry and behavioral aspects. Pharmacol. Ther. 64, 291 (1994) https://doi.org/10.1016/0163-7258(94)90041-8
  2. Kebabian, J. W. and Calne, D. B. : Multiple receptors for dopamine. Nature 277, 93 (1979) https://doi.org/10.1038/277093a0
  3. Sokoloff, P., Giros, B., Martres, M., Bouthene, M. and Schwarz, J. : Molecular cloning and characterization of novel dopamine receptor $D_{3}$ as a target for neuroleptics. Nature 347, 146 (1990)
  4. Van Tol, H. H. M., Bunzow, J. R., Guan, H. C., Sunhara, R. K., Man, P., Niznik, H. B. and Civelli, O. : Cloning of the gene for human dopamine $D_{4}$ receptor with high affinity for the antipsychotic clozapine. Nature 350, 610 (1991) https://doi.org/10.1038/350610a0
  5. Sunhara, R. K., Guan, H. C., O'Dowd, B. F., Seeman, P., Laurier, L. G., George, S. R., Torchia, J., Van Tol, H. H. M. and Niznik, H. B. : Cloning of the gene for a human dopamine $D_{5}$ receptor with higher affinity for dopamine than $D_{1}$. Nature 350, 614 (1991) https://doi.org/10.1038/350614a0
  6. Civelli, O., Bunzow, J. R. and Grandy, D. K. : Molecular diversity of the dopamine receptor. Annu. Rev. Pharmacol. Toxicol. 32, 281 (1993)
  7. Cannon, J. G., Perez, J. Z., Bhatnage,r R. K., Long, J. P. and Sharabi, F. M. : Conformationally restricted congeners of dopamine derived from 2-aminoindan. J. Med. Chem. 25(12), 1442 (1982) https://doi.org/10.1021/jm00354a010
  8. Cannon, J. G., Dushin, R. G., Long, J. P., Ilhan, M., Jones, N. D. and Schwarzendruber, J. K. : Synthesis and dopaminergic activity of (R)- and (S)-4-hydroxy-2-(di-n-propylamino)indan. J. Med. Chem. 28(4), 515 (1985) https://doi.org/10.1021/jm00382a024
  9. Ma, S. X., Long, J. P., Flynn, J. R., Leonard, P. A. and Cannon, J. G. : Dopaminergic structure-activity relationships of 2- aminoindan and cardiovascular action and dopaminergic activity of 4-hydroxy-5-methyl-2-di-n-propylaminoindan (RD- 211). J. Pharmacol. Exp. Ther. 256(2), 751 (1991)
  10. Gray, A. P., Kreifels, S. E. and Li, J. A. : Conformational requirements for direct adrenergic stimulantion. J. Med. Chem. 16, 1023 (1973) https://doi.org/10.1021/jm00267a014
  11. Haadsma-Svensson, S. R., Cleek, K. A., Dinh, D. M., Duncan, J. N., Haber, C. L., Huff, R. M., Lajiness, M. E., Nichols, N. F., Smith, M. W., Svebsson, K. A., Zaya, M. J., Carlsson, A. and Lin, C .H. : Dopamine $D_{3}$ receptor antagonists. 1. Synthesis and structure-Activity relationships of 5,6-dimethoxy-N-alkyland N-alkylaryl-substituted 2-aminoindans. J. Med. Chem. 44, 4716 (2001) https://doi.org/10.1021/jm010145w
  12. Gendreau, P. L., Petitto, J. M., Schnauss, R., Frantz, K. J., Van Hartesveldt, C., Gariepy, J. L. and Lewis, M. H. : Effects of the putative $D_{3}$ dopamine receptor antagonist PNU-99194A on motor behavior and emotional reactivity in C57BL/6J mice. Eur. J. Pharmacol. 337, 147 (1997) https://doi.org/10.1016/S0014-2999(97)01324-1
  13. Sterling, J., Veinberg, A., Lerner, D., Goldenberg, W.,; Levy, R., Youdim, M. and Finberg, J. : (R)-(${\pm}$)-N-Propargyl-1- aminoindan (rasagiline) and derivatives : highly selective and potent inhibitors of monoamine oxidase B. J. Neural Transm. Suppl. 52, 301 (1998)
  14. Klodzinska, A., Tatarczynska, K. and Stachowicz, E. : 1- Aminoindan-1,5-dicarboxylic acid (AIDA), a rigid (carboxyphenyl) glycine derivative acting on metabotropic glutamate receptors (mGluRs) antagonist. Pharmacology 281(2), 721 (1997)
  15. Carr, K. D., Yamamoto, N., Omura, M., Cabeza de Vaca, S. and Krahne, L. : Effects of the $D_{3}$ dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and foodrestricted rats. Psychopharmacology 163, 76 (2002) https://doi.org/10.1007/s00213-002-1132-0
  16. Baker, L. E., Svensson, K. A,, Garner, K. J. and Goodwin, A. K. : The dopamine $D_{3}$ receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for d-amphetamine or cocaine. Eur. J. Pharmacol. 358, 101(1998) https://doi.org/10.1016/S0014-2999(98)00582-2
  17. Akunne, H. C., Towners, P., Ellis, G. J., Dijkstra, D., Wikstrom, H., Heffner, T. G., Wise, L. D. and Pugsley, T. A. : Characterization of binding of $[^{3}H]PD$ 128907, a selective dopamine $D_{3}$ receptor agonist ligand, to CHO-K1 cells. Life Sci. 57, 1401 (1995) https://doi.org/10.1016/0024-3205(95)02102-O
  18. Dijksra, D., Hazelhoff, B., Mulder, T. B. A., de Vries, J. B., Wynberg, H. and Horn, A. S. : Synthesis and pharmacological activity of the hexahydro-4H-naphth[1,2-b][1,4]oxazines: a new series of potent dopamine receptor agonists. Eur. J. Med. Chem. 20, 247 (1985)
  19. Goksu, S. and Secen, H. : Concise syntheses of 2-aminoindans via indan-2-ol. Tetrahedron 61, 6801 (2005) https://doi.org/10.1016/j.tet.2005.04.069
  20. Panetta, C. A., Sha, D., Torres, E., He, Z., Hussey, C. L., Fang, Z. and Heimer, N. E. Tetracyano-4,7-indanquinodimethanes: The first TCNQs with an indan nucleus. Synthesis 9, 1085 (1997)